ME
23andMe Holding Co.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.61
+0.00%Margins
Gross margin
53.3%
EBITDA margin
-80.8%
EBIT margin
-114.0%
Net margin
-134.5%
FCF margin
-92.0%
-721.8%
Return on equity
-163.0%
Return on assets
-334.0%
Return on invested capital
1.15x
Asset turnover
-$155.3M
Cash from operations
$1.45
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2025